Feasibility Study to Evaluate Safety of Nutriseal™ Nutriplace™ System
NCT03371160 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22
Last updated 2024-06-18
Summary
This is a single center, non-randomized feasibility clinical evaluation that is designed to affirm the safety of the Nutriplace™ System guidance during the placement of the Nutriseal™ enteral feeding tubes.
Conditions
- Enteral Nutrition
Interventions
- DEVICE
-
Nutriplace™ System
The Nutriseal™ Nutriplace™ System is an electromagnetic tracking system for feeding tube placement designed to aid qualified operators in the placement of the Nutriseal™ Enteral Feeding Tube™ into the stomach or small intestine.
Sponsors & Collaborators
-
Nutriseal L.P
lead INDUSTRY
Principal Investigators
-
May Olayan, MD · The Cleveland Clinic
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-13
- Primary Completion
- 2018-03-15
- Completion
- 2018-03-15
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%E
NCT06842134 ·Status: COMPLETED ·Phase: PHASE1
-
Escalating Temporary Gastric Electrical Stimulation (GES) for Severe Gastroparesis
NCT02164591 ·Status: TERMINATED
-
Multi-Channel Gastric Electrical Stimulation for the Treatment of Gastroparesis
NCT00595621 ·Status: COMPLETED ·Phase: NA
-
Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends
NCT07341464 ·Status: RECRUITING ·Phase: NA
-
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
NCT01571297 ·Status: COMPLETED ·Phase: PHASE2
-
Gastric Pacemaker Implantation for Gastroparesis
NCT00568373 ·Status: WITHDRAWN ·Phase: NA
-
Prospective Monocentric Study on the Efficacy of Lidocain Spray for Patient Comfort During Nasogastric Tube Insertion in Enteral Nutrition
NCT02022059 ·Status: COMPLETED ·Phase: PHASE3
-
Nocturnal Cyclic Enteral Nutrition Infusion Versus Continuous Infusion of Enteral Nutrition
NCT03727165 ·Status: WITHDRAWN ·Phase: NA
-
Nutritional Tolerance and Safety of a Tube Feeding Formula
NCT05848583 ·Status: TERMINATED ·Phase: NA
-
Enterra Therapy Clinical Study (Gastric Stimulation for Gastroparesis)
NCT00157755 ·Status: TERMINATED ·Phase: NA
-
Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis
NCT01718938 ·Status: COMPLETED ·Phase: PHASE2
-
A Single Arm Intervention Study to Assess the Acceptability, Tolerance and Ease of Use of Wilbo's Blends+ (Commercial Enteral Feed Based on Real Food) When Used as Part of a Dietitian Prescribed Enteral Feeding Plan
NCT07036081 ·Status: COMPLETED ·Phase: NA
-
Initial Parenteral Nutrition Education of Parent Assessment Plan
NCT04816734 ·Status: COMPLETED ·Phase: NA
-
Enhanced Protein-Energy Provision Via the Enteral Route in Critically Ill Patients
NCT01102348 ·Status: COMPLETED ·Phase: NA
-
Temporary Gastric Electrical Stimulation for Gastroparesis
NCT01054794 ·Status: COMPLETED ·Phase: NA
-
Effect of Methylnaltrexone (Relistor) on Digestion and Tolerance to Tube Feeding in Patients Treated With Opiates
NCT01360372 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study of Enhanced Programming Stimulation with the Enterra® Therapy System
NCT06560307 ·Status: RECRUITING ·Phase: NA
-
Timing of Initiation of Parenteral Nutrition for Critically Ill Children
NCT04693143 ·Status: UNKNOWN ·Phase: NA
-
Thoracic Splanchnic Magnetic Neuromodulation Therapy (ThorS-MagNT) for Grade 3 Diabetic Gastroparesis: Pilot Study
NCT04706832 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Comparative Phase 3 Trial to Assess the Safety and Efficacy of Triple-chamber Parenteral Nutrition Formulation
NCT01579097 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Tolerance and Safety of Early Enteral Nutrition in Children After Percutaneous Endoscopic Gastrostomy Placement
NCT02777541 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)
NCT00172185 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE Trial
NCT02784392 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome
NCT00081458 ·Status: COMPLETED ·Phase: PHASE3
-
Feeding Children Nasogastrically Versus Nasojejunally While Receiving Noninvasive Positive Pressure Ventilation
NCT01301352 ·Status: COMPLETED ·Phase: NA